title: Retrovirally transduced bone marrow stromal cells isolated from a mouse model of human osteogenesis imperfecta (oim) persist in bone and retain the ability to form cartilage and bone after extended passaging.
abstract: Bone marrow stromal cells isolated from a model of osteogenesis imperfecta (oim) mice, were transduced with a retrovirus (BAG) carrying the LacZ and neor genes after passage 21. The transduced cells retained the ability to express alkaline phosphatase activity in vitro when treated with recombinant human bone morphogenetic protein two (rhBMP-2), formed cartilage in vitro in aggregate cultures and formed bone in ceramic cubes after 6 weeks of implantation in nude mice. X-gal staining of ceramic cubes seeded with the transduced cells demonstrated the presence of LacZ-positive cells on the edges of bone and also in the lacunae of the newly formed bone 6 weeks after implantation. After infusion into femurs of oim mice, the transduced cells were detected in the marrow cavity and on the edges of the trabecular bone of the injected and contralateral femurs by X-gal staining and PCR analysis at 4, 10, 20, 30 and 40 days after injection. The LacZ gene was also detected in the lung and liver of the recipient mice at 4 and 10 days after injection but not at later time-periods. The present findings suggest that long-term cultured bone marrow stromal cells from osteogenesis imperfecta (OI) animals have the potential to traffic through the circulatory system, home to bone, form bone and continue to express exogenous genes. These findings open the possibility of using these cells as vehicles to deliver normal genes to bone as an alternative approach for the treatment of some forms of OI and certain other bone acquired and genetic diseases.
authors.affiliation: University of Pittsburgh School of Medicine, Department of Orthopaedic Surgery, PA 15213, USA.
authors.forename: M
authors.initials: M
authors.lastname: Oyama
authors.forename: A
authors.initials: A
authors.lastname: Tatlock
authors.forename: S
authors.initials: S
authors.lastname: Fukuta
authors.forename: K
authors.initials: K
authors.lastname: Kavalkovich
authors.forename: K
authors.initials: K
authors.lastname: Nishimura
authors.forename: B
authors.initials: B
authors.lastname: Johnstone
authors.forename: P D
authors.initials: PD
authors.lastname: Robbins
authors.forename: C H
authors.initials: CH
authors.lastname: Evans
authors.forename: C
authors.initials: C
authors.lastname: Niyibizi
mesh_terms: D000469:Alkaline Phosphatase / Q000378:metabolism; D000818:Animals; D001854:Bone Marrow Cells; D002454:Cell Differentiation; D004195:Disease Models, Animal; D015870:Gene Expression; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors / Q000008:administration & dosage*; D006801:Humans; D007763:Lac Operon / Q000235:genetics; D008099:Liver / Q000378:metabolism; D008168:Lung / Q000378:metabolism; D051379:Mice; D008819:Mice, Nude; D010013:Osteogenesis Imperfecta / Q000378:metabolism / Q000473:pathology / Q000628:therapy*; D012190:Retroviridae / Q000235:genetics*; D014162:Transfection / Q000379:methods*
chemical_list: D000469:Alkaline Phosphatase